The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Moderna plans to advance research on the mRNA vaccine into a phase 3 trial after receiving positive results in earlier phases ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

MRNA intends to use the funds to support the development of its mRNA-based bird flu shot and expand clinical studies for ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

Georgia officials halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 ...

Merck stands to lose $62 billion over four years following the loss of exclusivity on KEYTRUDA, making Moderna's $13 billion market cap a bargain. The worsening Avian Flu crisis adds optionality ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight ...